IOmx Therapeutics

Munich, Germany

iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.

$75.4M raised

Oct 2021

Series B

Biopharma Health Care Pharmaceutical

Top Investors

Sofinnova Partners Wellington Partners MPM Capital M Ventures MIG Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about IOmx Therapeutics

How much funding has IOmx Therapeutics raised?

IOmx Therapeutics has raised $75.4M in total funding. The most recent round was Series B. The last funding was announced in October 2021.

Who are IOmx Therapeutics's investors?

IOmx Therapeutics's investors include Sofinnova Partners, Wellington Partners, MPM Capital, M Ventures, MIG Capital.

Where is IOmx Therapeutics headquartered?

IOmx Therapeutics is headquartered in Munich, Germany.

What does IOmx Therapeutics do?

iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.

What stage is IOmx Therapeutics at?

IOmx Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 5, 2021.

MLA

"IOmx Therapeutics — Funding & Investors." VCBacked, October 5, 2021, https://www.vcbacked.co/company/iomx-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). IOmx Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/iomx-therapeutics

Wikipedia (cite web)

{{cite web |title=IOmx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iomx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 5, 2021.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.